Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
3.
Indian J Ophthalmol ; 56(4): 313-6, 2008.
Article in English | MEDLINE | ID: mdl-18579991

ABSTRACT

PURPOSE: To study the epidemiology and clinical profile of victims of ocular trauma in an urban slum population. MATERIALS AND METHODS: This cross-sectional study, conducted on 500 families each in three randomly selected urban slums in Delhi, collected demographic data for all members of these families, and clinical data for all those who suffered ocular trauma at any time, that required medical attention. Data was managed on SPSS 11.0. RESULTS: Of 6704 participants interviewed, 163 episodes of ocular trauma were reported by 158 participants (prevalence = 2.4%, confidence interval = 2.0 to 2.7) Mean age at trauma was 24.2 years. The association between the age of participants and the history of ocular trauma was significant ( P < 0.001), when adjusted for sex, education and occupation. Males were significantly more affected. Blunt trauma was the commonest mode of injury (41.7%). Blindness resulted in 11.4% of injured eyes ( P = 0.028). Of 6704 participants, 1567 (23.4%) were illiterate, and no association was seen between education status and trauma, when adjusted for sex and age at injury. A significant association was noted between ocular trauma and workplace (Chi-square = 43.80, P < 0.001), and between blindness and place (Chi-square = 9.98, P = 0.041) and source (Chi-square = 10.88, P = 0.028) of ocular trauma. No association was found between visual outcome and the time interval between trauma and first consultation (Chi-square = 0.50, P = 0.78), between receiving treatment and the best corrected visual acuity (Chi-square = 0.81, P = 0.81), and between the person consulted and blinding ocular trauma (Chi-square = 1.88, P = 0.170). CONCLUSION: A significant burden of ocular trauma in the community requires that its prevention and early management be a public health priority.


Subject(s)
Eye Injuries/epidemiology , Poverty Areas , Urban Population/statistics & numerical data , Adolescent , Adult , Blindness/epidemiology , Cross-Sectional Studies , Educational Status , Eye Injuries/etiology , Female , Humans , India/epidemiology , Male , Occupations
4.
Indian J Ophthalmol ; 53(4): 243-7, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16333172

ABSTRACT

PURPOSE: To evaluate the circadian rhythm of intraocular pressure (IOP) in primary chronic angle closure glaucoma (PCACG), primary open angle glaucoma (POAG), and normal eyes. METHODS: Cross-sectional study of newly diagnosed patients of POAG (60 eyes), PCACG following laser iridotomy (75 eyes), and age and sex matched normal controls (75 eyes). All subjects underwent applanation tonometry at 7 a.m., 10 a.m., 1 p.m., 4 p.m., 7 p.m., and 10 p.m. by a masked observer. Circadian rhythms were classified based upon the timing and presence of peak pressure. RESULTS: Age and gender in all three groups were comparable. Diurnal IOP fluctuations were significantly higher in PCACG (7.69+3.03 mmHg) and POAG (8.31+2.58 mmHg) groups compared to normal controls (4.83 + 2.46 mmHg). PCACG eyes and controls had similarly timed circadian rhythms, with PCACG eyes having a consistently higher IOP. At 7 and 10 a.m., IOP peaked more often in POAG eyes compared to PCACG eyes. A plateau type of circadian rhythm was most common in normal eyes. The timing of peak IOP could be significantly correlated with the type of primary glaucoma examined. CONCLUSION: Afternoon peaks were more common in postiridotomy PCACG eyes, similar to the rhythm in normal eyes. Morning peaks were more frequent in POAG eyes. Diurnal fluctuation > 6 mmHg, associated with an IOP of 21 mmHg or more was never seen in a normal eye.


Subject(s)
Circadian Rhythm , Glaucoma, Angle-Closure/physiopathology , Glaucoma, Open-Angle/physiopathology , Intraocular Pressure , Case-Control Studies , Chronic Disease , Female , Humans , Male , Middle Aged
6.
Acta Ophthalmol Scand ; 79(4): 354-8, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11453853

ABSTRACT

PURPOSE: To compare pars plana vitrectomy for dropped nucleus with and without perfluorocarbon liquid. METHODS: 24 eyes with dropped nucleus were randomized to undergo PPV with perfluorodecalin, (study, n=12) and without it (control, n=12). Visual acuity, IOP, visual evoked response and electroretinography were noted at study entry and up to 3 months after PPV. Humphrey perimetry was done at 3 months. RESULTS: Final visual acuity was >20/60 in 75% of study eyes and 41.6% of controls. The two groups were statistically comparable with regard to the above parameters before PPV and during follow-up. The timing of vitrectomy did not significantly influence the final visual acuity. A higher rate of complications was seen in the control group. CONCLUSIONS: Perfluorodecalin facilitated the procedure and possibly minimized complications, and was found to be safe for intraoperative use in terms of recovery of visual acuity, stable ERG and VER, and normal visual fields.


Subject(s)
Fluorocarbons/therapeutic use , Lens Nucleus, Crystalline/surgery , Lens Subluxation/surgery , Visual Fields/physiology , Vitrectomy , Adult , Aged , Electroretinography , Evoked Potentials, Visual , Female , Humans , Lens Nucleus, Crystalline/pathology , Lens Subluxation/etiology , Male , Middle Aged , Optic Nerve/physiology , Phacoemulsification/adverse effects , Retina/physiology , Treatment Outcome , Visual Acuity
7.
Indian J Pediatr ; 59(1): 91-101, 1992.
Article in English | MEDLINE | ID: mdl-1612664

ABSTRACT

The study was conducted in 2831 pregnant women with no diagnosed complication at the time of registration to obtain normal foetal growth pattern for clinical and ultrasonographic parameters. Normal values for maternal weight, fundal height and abdominal girth for clinical and biparietal diameter, abdominal circumferences and femoral length for ultrasonographic parameters are presented. Clinical and ultrasonographic parameters were compared for their efficacy in prediction of low birth weight. Neither clinical nor ultrasonographic parameters were found to be satisfactory in identifying the foetus at risk of low birth weight. It has been found that clinical parameters for routine monitoring are as effective as ultrasonographic parameters and have the added advantage of being easily replicable at the peripheral level of health care.


Subject(s)
Fetal Growth Retardation/diagnostic imaging , Ultrasonography, Prenatal , Adult , Birth Weight , Body Weight , Embryonic and Fetal Development , Female , Fetal Growth Retardation/epidemiology , Humans , India , Infant, Newborn , Multivariate Analysis , Predictive Value of Tests , Pregnancy , Reference Values , Risk Factors , Sensitivity and Specificity
8.
Contraception ; 39(1): 37-52, 1989 Jan.
Article in English | MEDLINE | ID: mdl-2491981

ABSTRACT

A total of 1905 subjects were randomly allocated to four types of intrauterine devices (IUDs) and were observed for 45,683 woman-months of use. While no method failure was observed with levonorgestrel (LNG) IUD, 11 women became pregnant with other devices; 4 with Copper T 380Ag, 1 with Copper T 220C, and 6 while using Copper T 200B, indicating method failure rates of 1.0, 0.3 and 1.6, respectively, at 36 months of use. These rates were within acceptable range. Continuation rates were significantly lower with LNG IUD (74.5, 58.7, 38.8 at 1 year, 2 years and 3 years, respectively) as compared to other copper devices, which ranged between 82.4 to 84.4 at 1 year, 66.6 to 69.9 at 2 years and 45.4 to 50.4 at 3 years. The difference in continuation rates was mainly due to menstrual disturbances (e.g. amenorrhoea, irregular bleeding) which were higher with LNG IUD (27.9 per 100 users) as compared to the copper devices (13.4-15.4 per 100 users) at 36 months of use. The risk of expulsion ranged between 8.3 to 10.6 per 100 users and was comparable for all the devices. The observations from the present study based on 36 months of experience with different intrauterine devices do not indicate the need to replace CuT 200, the device currently in use in the National Programme.


Subject(s)
Intrauterine Devices, Copper , Intrauterine Devices, Medicated , Norgestrel/administration & dosage , Adolescent , Adult , Female , Humans , Infections/etiology , Intrauterine Device Expulsion , Intrauterine Devices, Copper/adverse effects , Intrauterine Devices, Medicated/adverse effects , Levonorgestrel , Menstruation Disturbances/etiology , Norgestrel/adverse effects , Pregnancy , Uterine Perforation/etiology
9.
Contraception ; 30(6): 561-74, 1984 Dec.
Article in English | MEDLINE | ID: mdl-6397328

ABSTRACT

A total of 2388 subjects, 1181 for 60 +/- 5-day and 1207 for 90 +/- 5-day treatment regimen with norethisterone oenanthate (NET OEN) 200 mg injection, were observed for 24 months, constituting 28,513 woman-months. This clinical trial represents the largest clinical trial undertaken on NET OEN. The observations indicated that NET OEN given at 60 +/- 5-day intervals provides adequate contraceptive protection. However, as compared to the published studies elsewhere, higher method failures were seen during the first six months of NET OEN usage, when all women were receiving the drug at 60 +/- 5-day intervals. The reasons for this discrepant observation in the present study cannot be explained. The higher method failures reported with 90 +/- 5-day regimen were mainly during the third month following the injection, suggesting reduced contraceptive efficacy of the drug during this period. Thin build women (body weight less than or equal to 40 kg) were at higher risk of involuntary pregnancy. Disrupted menstrual pattern was the major reason for discontinuation ranging between 42-43 per 100 users at the end of 24 months. Amongst these, amenorrhoea was the commonest reason for discontinuation. No change in blood pressure was observed during contraceptive usage. The majority of NET OEN users did not show any change in body weight. The overall continuation rates with NET OEN were lower than those observed in similar conditions with Cu-T 200 mm2 IUCD.


Subject(s)
Contraceptive Agents, Female/administration & dosage , Fertility/drug effects , Norethindrone/analogs & derivatives , Adult , Body Weight , Clinical Trials as Topic , Contraceptive Agents, Female/adverse effects , Drug Administration Schedule , Female , Humans , India , Injections, Intramuscular , Norethindrone/administration & dosage , Norethindrone/adverse effects , Pregnancy , Risk
SELECTION OF CITATIONS
SEARCH DETAIL
...